FindTrial
Sign In

The coagulation function of novel coronavirus pneumonia (COVID-19) patients

The coagulation function of novel coronavirus pneumonia (COVID-19) patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030257
Enrollment
Unknown
Registered
2020-02-26
Start date
2020-03-09
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

Puren Hospital of Wuhan City
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: the diagnosed COVID-19 pneumonia inpatients

Exclusion criteria

Exclusion criteria: blood disease, hepatosis, maglinant tumor, other diseases affecting coagulation function. and taking anticoagulation drugs.

Design outcomes

Primary

MeasureTime frame
INR;PT;TT;APTT;FIB;DD;—

Countries

China

Contacts

Public ContactLi Jiangping

Puren Hospital of Wuhan City

1078404424@qq.com+86 18602764053

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026